Hirsch Stanley 4
4 · Foamix Pharmaceuticals Ltd. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
Hirsch Stanley
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2019-11-04$0.62/sh+32,500$20,150→ 182,500 total(indirect: See footnote) - Exercise/Conversion
Options
2019-11-04−32,500→ 0 total(indirect: See footnote)Exercise: $0.62From: 2004-01-01Exp: 2019-11-25→ Ordinary Shares (32,500 underlying)
Holdings
- 69,365
Ordinary Shares
Footnotes (2)
- [F1]Securities are held by ZEAS Technology and Science Management Ltd., a company beneficially owned by Stanley Hirsch.
- [F2]This security represents ordinary shares and restricted share units. Each restricted share unit represents a contingent right to receive one ordinary share of the issuer.